Histology & Cytology Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Japan, China, India, Australia, South Korea, Mexico, Brazil, Argentina, Saudi Arabia, South Africa, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Report ID: GMI3736

  Table of Contents Inquiry Before Buying
Summary Methodology Customize this Report

Histology & Cytology Market size is expected to grow significantly from 2019 to 2025.
 

Increasing disease burden in developed as well as developing economies is the key factor driving histology & cytology market growth. According to World Health Organization, cancer is one of the leading causes of morbidity and mortality worldwide, accounting for around 9.5 million deaths in 2018. Additionally, cancer causing infections including human papilloma virus (HPV) and hepatitis, account for approximately 25% of cancer cases in low and middle-income economies. Moreover, growing preference towards cytological tests due to its less invasive nature and high reliability as compared to biopsy will favor histology & cytology industry growth over the forecast timeline.
 

Technological advancement in the cell and tissue studies will render positive impact on the histology & cytology industry growth. Continuous R&D efforts by industry players extend the scope of its application in diagnosis of numerous diseases. Moreover, favorable reimbursement policies for cancer screening and laboratory testing will further spur the business revenue. However, high cost of histology tests may hamper the histology & cytology market growth during the forthcoming years.
 

Cytology segment accounted for significant revenue share in 2018 and is projected to grow substantially over the forecast timeframe. Wide adoption of cytology tests in cancer detection and screening will increase its demand over the coming years. Wide adoption of specialized cytology tests for cellular level observations in diagnosis of various cancers including cervical and breast cancer will favor segment growth.
 

The academic and research institutes segment held momentous revenue share in 2018. Growing funding by private and public organizations in various research & development activities will stimulate business growth over the forecast period. Researchers and scientists are adopting new flexible techniques for research studies owing to innovation and modernization in histology & cytology techniques, resulting in segment growth.
 

North America histology & cytology market held significant revenue share in 2018 and is estimated to show similar trend over the forecast period. According to the National Cancer Institute, more than 1,735,300 new cancer cases and around 609,600 cancer deaths were recorded in 2018. Thus, increasing research activities in the region focusing on cancer diagnosis and treatment will augment North America histology & cytology industry growth.
 

Asia Pacific histology & cytology market is expected to witness lucrative growth over the analysis period. Large patient pool in the region suffering from various infectious diseases will favor regional growth. Surging demand for efficient sample testing resulting in timely treatment and faster patient outcomes will accelerate regional business growth during the forthcoming years.
 

Some of the eminent players operating in histology & cytology market are Abbott Laboratories, Becton Dickinson & Company, Danaher, F. Hoffmann-La Roche, Hologic, Merck, Perkin Elmer, Sysmex Corporation, Thermo Fisher Scientific, Trivitron Healthcare and Life Technologies. The industry players mainly focus on strategic alliances such as collaborations and acquisitions to increase existing customer base and gain more revenue.
 

Histology & Cytology Market By Examination Type, 2014-2025 (USD Million)

  • Histology
  • Cytology
    • Breast Cancer
    • Cervical Cancer
    • Others

Histology & Cytology Market By Test Type, 2014-2025 (USD Million)

  • Microscopy tests
    • Cytogenic tests
      • Karyotyping
      • Fluorescent In-situ Hybridization (FISH)
    • Polymerase Chain Reaction
    • Others
  • Molecular genetics tests
  • Flow cytometry
  • Others

Histology & Cytology Market By End-use, 2014-2025 (USD Million)

  • Hospitals
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE

Company Profiles:

  • Abbott Laboratories
  • Becton Dickinson & Company
  • Danaher
  • F. Hoffmann-La Roche
  • Hologic
  • Merck
  • Perkin Elmer
  • Sysmex Corporation
  • Thermo Fisher Scientific
  • Trivitron Healthcare
  •  Life Technologies

What Information does this report contain?

Historical data coverage: 2014 to 2018; Growth Projections: 2019 to 2025.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.


Customize this Report

Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability

Why Global Market Insights?

 Comprehensive Research
  • All-inclusive coverage
  • In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
  • Penetrative insights & latest trends
  • Offers holistic understanding of the market
 Data Accuracy & Reliability
  • Unique methodology
  • Iterative in nature to eliminate errors
  • Detailed methodology, scope, assumptions and data sources available for reference
 Post-Sales Support
  • Committed to making a positive difference for our clients
  • Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
  • Every purchase comes with an option to obtain additional information:
    • up to 10% of the original cost
    • 45-minute analyst tele-call to obtain further clarity on the market.
 Security & Confidentiality
  • Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
  • Only PCI-DSS compliant payment methods used for highest level of client data security
This site is protected by Trustwave's Trusted Commerce program Authorize.Net Merchant - Click to Verify

Connect with our sales team

Chat With Us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info. I Agree